Survey Reveals 55% of HIV Care Providers Face Stock Shortages
A recent survey highlights alarming shortages of essential HIV medications and tests due to aid cuts, impacting global health efforts.
Over half of HIV care providers reported stock shortages in the past year.
40% of surveyed organizations ran out of key products entirely.
Cuts in aid spending threaten to reverse years of progress against HIV.
A new survey conducted by the International Planned Parenthood Federation (IPPF) has revealed that more than half of HIV care providers globally have experienced significant shortages of essential medications and testing supplies. This alarming trend, reported by organizations across 40 countries, underscores the critical impact of recent aid cuts on HIV treatment and prevention efforts.
The survey findings indicate that 55% of the organizations surveyed ran out of stock of vital HIV-related products within the last year. Specifically, 40% of respondents reported complete depletion of at least one product, while 60% indicated that they were operating with low stock levels. The most affected items included rapid diagnostic tests and pre-exposure prophylaxis (PrEP), which are crucial for preventing HIV transmission.
Mallah Tabot, a senior adviser at IPPF Africa, emphasized the urgency of the situation, stating that these shortages serve as a warning about the fragility of supply systems when funding becomes uncertain. She noted that the resurgence of HIV infections in various countries is a direct consequence of these supply issues, leading to preventable loss of life. The data shows that many organizations are struggling to provide consistent testing services, with over half unable to offer sustained HIV testing at the point of care due to stock shortages.
The implications of these shortages extend beyond individual health services, affecting broader public health initiatives in regions such as the Arab world, Asia, Oceania, Europe, and the Americas. Respondents reported unreliable supplies of not only HIV medications but also essential items like condoms and antiretroviral therapy. Lori Miller, an HIV adviser for IPPF, highlighted that while partners possess the necessary infrastructure to deliver integrated care, inconsistent supplies hinder their efforts to reach those in need.
Looking ahead, the situation remains precarious as global aid spending has seen a significant decline, with a reported 23% drop in 2025 compared to the previous year. This reduction in funding poses a serious risk of reversing years of progress made in combating the HIV epidemic. As the UN has warned, without immediate action to stabilize funding and supply chains, the world may witness a resurgence of HIV infections and related health crises.
